PeptiVA
KLOW 80 mg injection pen
Injection Pen

KLOW

GHK-Cu + BPC-157 + TB-500 + KPV

KLOW combines GHK-Cu, BPC-157, TB-500 and KPV into a single regenerative blend — the most comprehensive regeneration option available — used across skin remodelling, systemic tissue repair and inflammatory signalling. Typical Course: A full course runs 12 weeks. It begins with a 2-week phase at a lower dose (2mg once daily) so you can assess individual tolerance to the blend, followed by a 10-week phase at 4mg once daily in the morning, when systemic activity is optimal. Most customers notice initial effects around week 2, with results peaking around week 8. What to Expect: Faster recovery, improved skin and collagen quality, reduced inflammation and improved overall tissue health. Key benefits include four compounds in a single formulation, comprehensive regeneration, convenient once-daily administration and synergistic compound action. Considerations & Safety: Because this is a multi-compound blend, individual compound effects cannot be isolated, and sensitivity to one of the components is possible. Common side effects include injection site redness, mild nausea, headache and temporary fatigue. Seek medical attention immediately if you notice signs of infection, severe allergic reaction, persistent worsening symptoms, or high fever.

Active Dosage

80 mg

Purity

99%+

Select dosage
1
Total

1,100 AED

SequenceAvailable on request
Molecular FormulaAvailable on request
Molecular WeightAvailable on request
CAS NumberAvailable on request
FormReconstituted injection pen
Purity≥ 99%+

Related Compounds